Arinola, G. O., Jimoh, M. A., Adigun, K., & Oshingbesan, M. B. Serum tumour marker (CEA, CA 19-9 and CA 27-29) levels and their association with clinicopathological parameters in Nigerian breast cancer patients. Via Medica.
Chicago Style (17th ed.) CitationArinola, Ganiyu Olatunbosun, Mutiu Alani Jimoh, Kehinde Adigun, and Mosunmade Babatunde Oshingbesan. Serum Tumour Marker (CEA, CA 19-9 and CA 27-29) Levels and Their Association with Clinicopathological Parameters in Nigerian Breast Cancer Patients. Via Medica.
MLA (9th ed.) CitationArinola, Ganiyu Olatunbosun, et al. Serum Tumour Marker (CEA, CA 19-9 and CA 27-29) Levels and Their Association with Clinicopathological Parameters in Nigerian Breast Cancer Patients. Via Medica.
Warning: These citations may not always be 100% accurate.